Mutations of the PTPN11 gene in therapy-related MDS and AML with rare balanced chromosome translocations

Genes Chromosomes and Cancer

Volumn 46, Issue 6, 2007, Pages 517-521

  Christiansen, Debes H ^a   Desta, Frehiwet ^a   Andersen, Mette K ^a,b   Pedersen Bjergaard, Jens ^a  

^a Rigshospitalet   (Denmark)

^b Department of Clinical Genetics ^*  (Denmark)

Author keywords

[No Author keywords available]

Indexed keywords

ACUTE GRANULOCYTIC LEUKEMIA; ADULT; AMINO ACID SUBSTITUTION; ARTICLE; CHROMOSOME 3Q; CHROMOSOME 7Q; CHROMOSOME DELETION; CHROMOSOME LOSS; CHROMOSOME TRANSLOCATION 21; CONTROLLED STUDY; EVI1 GENE; EXON; FEMALE; GENE; GENE MUTATION; GENE REARRANGEMENT; GENETIC ASSOCIATION; HUMAN; HUMAN CELL; MAJOR CLINICAL STUDY; MALE; MUTATIONAL ANALYSIS; MYELODYSPLASIA; NUCLEIC ACID BASE SUBSTITUTION; PRIORITY JOURNAL; PTPN11 GENE; RUNX1 GENE;

ACUTE DISEASE; AGED; FEMALE; HUMANS; INTRACELLULAR SIGNALING PEPTIDES AND PROTEINS; LEUKEMIA, MYELOCYTIC, ACUTE; LEUKEMIA, MYELOID; MALE; MIDDLE AGED; MOLECULAR SEQUENCE DATA; MUTATION; MYELODYSPLASTIC SYNDROMES; PROTEIN-TYROSINE-PHOSPHATASE; SEQUENCE ANALYSIS, DNA; TRANSLOCATION, GENETIC;

EID: 34247518152     PISSN: 10452257     EISSN: 10982264     Source Type: Journal    
DOI: 10.1002/gcc.20426     Document Type: Article

References (22)

1. Bader-Meunier B, Tchernia G, Mielot F, Fontaine JL, Thomas C, Lyonnet S, Lavergne JM, Dommergues JP. 1997. Occurrence of myeloproliferative disorders in patients with Noonan syndrome. J Pediatr 130:885-889.
2. Chen Y, Takita J, Hiwatari M, Igarashi T, Hanada R, Kikuchi A, Hongo T, Taki T, Ogasawara M, Shimada A, Hayashi Y. 2006. Mutations of the PTPN11 and RAS genes in rhabdomyosarcoma and pediatric haematological malignancies. Genes Chromosomes Cancer 45:583-591.
3. Christiansen DH, Andersen MK, Pedersen-Bjergaard J. 2004. Mutations of AML1 are common in therapy-related myelodysplasia following therapy with alkylating agents and are significantly associated with deletion or loss of chromosome arm 7q and with subsequent leukemic transformation. Blood 104:1474-1481.
4. Christiansen DH, Andersen MK, Desta F, Pedersen-Bjergaard J. 2005. Mutations of genes in the receptor tyrosine kinase (RTK)/RAS-BRAF signal transduction pathway in therapy-related myelodysplasia and acute myeloid leukemia. Leukemia 19:2232-2240.
5. Deguchi K, Gilliland DG. 2002. Cooperativity between mutations in tyrosine kinases and in hematopoietic transcription factors in AML. Leukemia 16:740-744.
6. Johannes JM, Garcia ER, De Vaan GA, Weening RS. 1995. Noonan syndrome in association with acute leukemia. Pediatr Hematol Oncol 12:571-575.
7. Kelly LM, Gilliland DG. 2002. Genetics of myeloid leukemias. Annu Rev Genomics Hum Genet 3:179-198.
8. Kratz CP, Niemeyer CM, Castleberry RP, Cetin M, Bergstrasser E, Emanuel PD, Hasle H, Kardos G, Klein C, Kojima S, Stary J, Trebo M, Zecca M, Gelb BD, Tartaglia M, Loh ML. 2005. The mutational spectrum of PTPN11 in juvenile myelomonocytic leukemia and Noonan syndrome/myeloproliferative disease. Blood 106:2183-2185.
9. Loh ML, Reynolds MG, Vattikuti S, Gerbing RB, Alonzo TA, Carlson E, Cheng JW, Lee CM, Lange BJ, Meshinchi S, Children's Cancer Group. 2004a. PTPN11 mutations in pediatric patients with acute myeloid leukemia: Results from the Children's Cancer group. Leukemia 18:1831-1834.
10. Loh ML, Vattikuti S, Schubbert S, Reynolds MG, Carlson E, Lieuw KH, Cheng JW, Lee CM, Stokoe D, Bonifas JM, Curtiss NP, Gotlib J, Meshinchi S, Le Beau MM, Emanuel PD, Shannon KM. 2004b. Mutations in PTPN11 implicate the SHP-2 phosphatase in leukemogenesis. Blood 103:2325-2331.
11. Niimi H, Harada H, Harada Y, Ding Y, Imagawa J, Inaba T, Kyo T, Kimura A. 2006. Hyperactivation of the RAS signal pathway in myelodysplastic syndrome with AML1/RUNX1 point mutations. Leukemia 20:635-644.
12. Pedersen-Bjergaard J, Rowley JD. 1994. The balanced and the unbalanced chromosome aberrations of acute myeloid leukemia may develop in different ways and may contribute differently to malignant transformation. Blood 83:2780-2786.
13. Piombo M, Rosanda C, Pasino M, Marasini M, Cerruti P, Comelli A. 1993. Acute lymphoblastic leukemia in Nonan syndrome: report of two cases. Med Pediatr Oncol 21:454-455.
14. Roumier C, Lejeune-Dumoulin S, Renneville A, Goethgeluck AS, Philippe N, Fenaux P, Preudhomme C. 2006. Cooperation of activating Ras/rtk signal transduction pathway mutations and inactivating myeloid differentiation gene mutations in M0 AML: A study of 45 patients. Leukemia 20:433-436.
15. Schubbert S, Lieuw K, Rowe SL, Lee CM, Li X, Loh ML, Clapp DW, Shannon KM. 2005. Functional analysis of leukaemia-associated PTPN11 mutations in primary hematopoietic cells. Blood 106:311-317.
16. Side LE, Shannon KM. 1997. Myeloid disorders in infants with Noonan syndrome and a resident's "rule" recalled. J Pediatr 130:857-859.
17. Tartaglia M, Mehler EL, Goldberg R, Zampino G, Brunner HG, Kremer H, van der Burgt I. Crosby AH, Ion A, Jeffery S, Kalidas K, Patton MA, Kucherlapati RS, Gelb BD. 2001. Mutations in PTPN11 encoding the protein tyrosine phosphatase SHP-2 cause Noonan syndrome. Nat Genet 29:465-468.
18. Tartaglia M, Niemeyer CM, Fragale A, Song X, Buechner J, Jung A, Hahlen K, Hasle H, Licht JD, Gelb BD. 2003. Somatic mutations in PTPN11 in juvenile myelomonocytic leukemia, myelodysplastic syndromes and acute myeloid leukemia. Nat Genet 34:148-150.
19. Tartaglia M, Martinelli S, Cazzaniga G, Cordeddu V, Iavarone I, Spinelli M, Palmi C, Carta C, Pession A, Arico M, Masera G, Basso G, Sorcini M, Gelb BD, Biondi A. 2004. Genetic evidence for lineage-related and differentiation stage-related contribution of somatic PTPN11 mutations to leukemogenesis in childhood acute leukemia. Blood 104:307-313.
20. Tartaglia M, Martinelli S, Stella L, Bocchinfuso G, Flex E, Cordeddu V, Zampino G, Burgt I, Palleschi A, Petrucci TC, Sorcini M, Schoch C, Foa R, Emanuel PD, Gelb BD. 2006. Diversity and functional consequences of germline and somatic PTPN11 mutations in human disease. Am J Hum Genet 78:279-290.
21. Thiede C, Steudel C, Schakel U, Ehninger G. 2004. Mutations of the SHP-2 proteine tyrosine phosphatase in adult patients with acute myeloid leukemia. Blood 104:165a (abstract 572).
22. Wieser R, Schreiner U, Rieder H, Pirc-Danoewinata H, Gruner H, Loncarevic IF, Fonatsch C. 2003. Interphase fluorescence in situ hybridization assay for the detection of rearrangements of the EVI-1 locus in chromosome band 3q26 in myeloid malignancies. Haematologica 88:25-30.